JPWO2021090888A1 - - Google Patents

Info

Publication number
JPWO2021090888A1
JPWO2021090888A1 JP2021555106A JP2021555106A JPWO2021090888A1 JP WO2021090888 A1 JPWO2021090888 A1 JP WO2021090888A1 JP 2021555106 A JP2021555106 A JP 2021555106A JP 2021555106 A JP2021555106 A JP 2021555106A JP WO2021090888 A1 JPWO2021090888 A1 JP WO2021090888A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021555106A
Other languages
Japanese (ja)
Other versions
JP7513034B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021090888A1 publication Critical patent/JPWO2021090888A1/ja
Application granted granted Critical
Publication of JP7513034B2 publication Critical patent/JP7513034B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2021555106A 2019-11-05 2020-11-05 タンパク質の製造方法 Active JP7513034B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019200753 2019-11-05
JP2019200753 2019-11-05
PCT/JP2020/041377 WO2021090888A1 (ja) 2019-11-05 2020-11-05 タンパク質の製造方法

Publications (2)

Publication Number Publication Date
JPWO2021090888A1 true JPWO2021090888A1 (cg-RX-API-DMAC7.html) 2021-05-14
JP7513034B2 JP7513034B2 (ja) 2024-07-09

Family

ID=75848562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021555106A Active JP7513034B2 (ja) 2019-11-05 2020-11-05 タンパク質の製造方法

Country Status (6)

Country Link
US (1) US12584156B2 (cg-RX-API-DMAC7.html)
EP (1) EP4056678A4 (cg-RX-API-DMAC7.html)
JP (1) JP7513034B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220097421A (cg-RX-API-DMAC7.html)
CN (1) CN114667351A (cg-RX-API-DMAC7.html)
WO (1) WO2021090888A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116064706A (zh) * 2022-11-10 2023-05-05 江苏江山聚源生物技术有限公司 通过调节磷酸浓度和添加方式提高重组胶原蛋白发酵水平的工艺

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01222793A (ja) * 1988-02-29 1989-09-06 Morinaga & Co Ltd モノクローナル抗体生産増強法
JPH01247097A (ja) * 1988-03-30 1989-10-02 Morinaga & Co Ltd モノクローナル抗体生産増強法
WO2007077217A2 (en) * 2006-01-04 2007-07-12 Baxter International Inc. Oligopeptide-free cell culture media
WO2008136398A1 (ja) * 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
WO2011134920A1 (en) * 2010-04-26 2011-11-03 Novartis Ag Improved cell culture medium
WO2011134921A1 (en) * 2010-04-26 2011-11-03 Novartis Ag Improved cell culture medium

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434857B1 (en) * 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
US6924124B1 (en) * 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
TWI369401B (en) * 2005-07-05 2012-08-01 Ares Trading Sa Serum-free culture medium for the production of recombinant gonadotropins
TW201516149A (zh) * 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
CN102994441A (zh) * 2012-09-19 2013-03-27 上海瀚康生物医药科技有限公司 一种细胞培养基及其制备方法和用途
CA2945390A1 (en) 2014-04-10 2015-10-15 Bayer Healthcare Llc Compounded media powder formulation and method of preparation of liquid medium for cell culture
WO2017090665A1 (ja) 2015-11-25 2017-06-01 味の素株式会社 フィブロイン様タンパク質の製造法
JPWO2017171001A1 (ja) 2016-03-31 2019-02-14 味の素株式会社 フィブロイン様タンパク質改変体および細胞培養方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01222793A (ja) * 1988-02-29 1989-09-06 Morinaga & Co Ltd モノクローナル抗体生産増強法
JPH01247097A (ja) * 1988-03-30 1989-10-02 Morinaga & Co Ltd モノクローナル抗体生産増強法
WO2007077217A2 (en) * 2006-01-04 2007-07-12 Baxter International Inc. Oligopeptide-free cell culture media
WO2008136398A1 (ja) * 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
WO2011134920A1 (en) * 2010-04-26 2011-11-03 Novartis Ag Improved cell culture medium
WO2011134921A1 (en) * 2010-04-26 2011-11-03 Novartis Ag Improved cell culture medium

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CYTOTECHNOLOGY, vol. 2, no. 1, JPN6020049435, February 1989 (1989-02-01), pages 63 - 67, ISSN: 0005248939 *
橋爪秀一、外: "ヒト型モノクローナル抗体の作製と生産", 日本農芸化学会誌, vol. 62, no. 10, JPN6020049436, 1988, pages 1513 - 1516, ISSN: 0005248940 *

Also Published As

Publication number Publication date
KR20220097421A (ko) 2022-07-07
US20220251622A1 (en) 2022-08-11
WO2021090888A1 (ja) 2021-05-14
JP7513034B2 (ja) 2024-07-09
US12584156B2 (en) 2026-03-24
EP4056678A1 (en) 2022-09-14
CN114667351A (zh) 2022-06-24
EP4056678A4 (en) 2023-12-06

Similar Documents

Publication Publication Date Title
BR112019017762A2 (cg-RX-API-DMAC7.html)
BR112021008711A2 (cg-RX-API-DMAC7.html)
BR112019016141A2 (cg-RX-API-DMAC7.html)
BR112019016142A2 (cg-RX-API-DMAC7.html)
BR112021012348A2 (cg-RX-API-DMAC7.html)
AT524962A5 (cg-RX-API-DMAC7.html)
BR112021013128A2 (cg-RX-API-DMAC7.html)
BR112019016136A2 (cg-RX-API-DMAC7.html)
BR102020020846B1 (pt) Niveladora, e, método para serviço em uma niveladora
BR102020020816B1 (pt) Veículo, e, método para controlar o movimento de ar através de um veículo com uma ventoinha do veículo
BR102020018650B1 (pt) Método para preparar óxido de cálcio usando um forno pré- aquecedor de suspensão de múltiplos estágios
BR102020017390B1 (pt) Bomba multifásica
BR102020016297B1 (pt) Bolsa de forro para um contentor e método para criar e prender uma bolsa de forro a um contentor
BR112021026535B1 (pt) MÉTODO DE DECODIFICAÇÃO/CODIFICAÇÃO DE IMAGEM REALIZADO POR UM APARELHO DE DECODIFICAÇÃO/CODIFICAÇÃO DE IMAGEM, MÉTODO DE TRANSMISSÃO DE UM FLUXO DE BITS GERADO POR UM MÉTODO DE CODIFICAÇÃO DE IMAGEM e MEIO DE GRAVAÇÃO LEGÍVEL POR COMPUTADOR NÃO TRANSITÓRIO
BR102020011722B1 (pt) Porta de tela para um pacote de radiadores
BR102020005984B1 (pt) Dispositivo de arranque-gerador combinado, e, conjunto de trem de acionamento
BR112021010564B1 (pt) Sistema de armadilha para animais e método de monitoramento do mesmo
BR112021014592B1 (pt) Compostos fotosensibilizadores, métodos de fabricação e aplicação em plantas
BR112021013954B1 (pt) Sistema de cateter com confirmação da colocação do cateter dentro de uma veia
BR112021013470B1 (pt) Conector de acesso sem agulha para facilitar a entrega de instrumento a um conjunto de cateter
BR102020000355B1 (pt) Embreagem que tem dois estágios para aplicar torque variado entre um eixo de entrada e um eixo de saída
BR102019027339B1 (pt) Sistema de aspersão de água e difusor de sistema de aspersão de água
BR102019026542B1 (pt) Sistema para detectar e controlar a posição de spoiler de asa de aeronave
BR102019026575B1 (pt) Atuador, e, aeronave
BR102019026293B1 (pt) Sistema de aeronave, e, método para transmitir energia de um primeiro componente para um segundo componente

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220907

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230718

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240130

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240328

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240528

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240610

R150 Certificate of patent or registration of utility model

Ref document number: 7513034

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150